Chronic lymphocytic inflammation with pontine perivascular enhancement responsive to steroids (CLIPPERS) after SARS-CoV-2 pneumonia

Jonathan Muri, Valentina Cecchinato, Andrea Cavalli, Akanksha A. Shanbhag, Milos Matkovic, Maira Biggiogero, Pier Andrea Maida, Jacques Moritz, Chiara Toscano, Elaheh Ghovehoud, Raffaello Furlan, Franca Barbic, Antonio Voza, Guendalina De Nadai, Carlo Cervia, Yves Zurbuchen, Patrick Taeschler, Lilly Murray, Gabriela Danelon-Sargenti, Simone G. Moro, Tao Gong, Pietro Piffaretti, Filippo Bianchini, Virginia Crivelli,

Article2021

Antibody Response After Initial Vaccination for SARS-CoV-2 in Patients With Amyloidosis

Efstathios Kastritis, Evangelos Terpos, Aimilia D. Sklirou, Foteini Theodorakakou, Despina Fotiou, Eleni‐Dimitra Papanagnou, Tina Bagratuni, Nikolaos Kanellias, Maria Gavriatopoulou, Ioannis P. Trougakos, Meletios A Dimopoulos

Chronic lymphocytic inflammation with pontine perivascular enhancement responsive to steroids (CLIPPERS) after SARS-CoV-2 pneumonia

Discussion(0)

Related publications

PB0088 Alterations in Thrombin Generation after SARS-CoV-2 Vaccination and the Relation with Inflammation

Rebound of COVID-19 infection in patients with chronic lymphocytic leukemia treated for SARS-CoV-2 with Nirmatrelvir/Ritonavir or Molnupiravir

Trends of Common Laboratory Biomarkers after SARS-CoV-2 Infection

Anti-chemokine antibodies after SARS-CoV-2 infection correlate with favorable disease course

Antibody Response After Initial Vaccination for SARS-CoV-2 in Patients With Amyloidosis